Telehealth has made hair loss prescriptions accessible at scale — but "accessible" and "clinically thorough" are not the same thing. The intake quality of telehealth hair platforms varies considerably, from basic questionnaire-to-prescription pipelines to clinically substantive evaluations. Understanding what distinguishes thoughtful intake from cursory processing matters for the care you receive.
What a Clinically Adequate Hair Loss Intake Covers
A clinically adequate hair loss evaluation — whether telehealth or in-person — should systematically address:
- Loss pattern characterization: Diffuse vs. patterned, vertex vs. temporal vs. hairline, rate of progression
- Duration: When loss was first noticed, whether it has been progressive or stable, any triggering events
- Family history: Both maternal and paternal sides, since AGA is polygenic with maternal-side influence frequently underweighted in patient self-assessment
- Relevant medications: Anabolic steroids, SARMs, high-dose testosterone, beta-blockers, and other medications with hair loss as a side effect
- Potential comorbidities: Thyroid dysfunction, iron deficiency, nutritional deficiency, autoimmune conditions
- Sexual function baseline: Pre-treatment documentation matters for interpreting any changes on finasteride
- Contraindications assessment: Liver function if dutasteride is considered, prostate-specific antigen (PSA) interpretation if relevant
Sexual side effects of finasteride are a genuine clinical phenomenon in a minority of users. Documenting baseline sexual function before prescribing creates a reference point for interpreting any changes. Platforms that skip this baseline are reducing their ability to clinically manage potential adverse effects.
Platform Intake Quality Spectrum
Telehealth hair platforms broadly fall into three tiers of intake quality:
| Tier | Intake Process | Photo Review | Clinician Involvement |
|---|---|---|---|
| Questionnaire-only | Text form, 5–10 questions | Optional self-upload, not required | Asynchronous review, minimal |
| Structured clinical intake | 15–25 questions including comorbidities and baselines | Required, clinician-reviewed | Asynchronous but substantive |
| Synchronous consultation | Video or phone consult with clinician | Live assessment or required uploads | Full synchronous evaluation |
Photo Quality and What It Reveals
Photograph assessment in telehealth is a pragmatic compromise. Trichoscopy, the gold-standard diagnostic tool, requires physical contact between the device and the scalp with 20–80x magnification. A patient's phone photo provides a rough picture of pattern and extent but cannot identify miniaturization, assess the vellus-to-terminal ratio, or reliably characterize scalp inflammation. Clinicians relying solely on submitted photos are working with limited data.
Some platforms address this by requiring standardized multi-angle photos (frontal, temporal, crown) and providing explicit instructions for lighting and distance. Better intake photos produce better clinical information.
Signs of Thorough vs. Cursory Intake
In evaluating a telehealth platform's intake quality, look for:
- Questions about comorbid conditions that could cause non-AGA hair loss
- Questions about other medications and supplements
- Baseline documentation of sexual function before prescribing finasteride
- PSA discussion for men over 40 (finasteride lowers PSA by approximately 50%, affecting prostate cancer screening interpretation)
- Photo requirements with standardization guidance
- Acknowledgment that diffuse thinning may require further workup before assuming AGA